IQ-AI (IQAI) Competitors GBX 0.81 -0.09 (-9.89%) As of 11:39 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock IQAI vs. TRLS, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, COG, and INHCShould you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry. IQ-AI vs. Trellus Health DeepVerge Sensyne Health EMIS Group Craneware Instem Kooth Renalytix Cambridge Cognition Induction Healthcare Group IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation. Do insiders & institutionals hold more shares of IQAI or TRLS? 19.3% of Trellus Health shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by insiders. Comparatively, 49.7% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community favor IQAI or TRLS? IQ-AI received 6 more outperform votes than Trellus Health when rated by MarketBeat users. CompanyUnderperformOutperformIQ-AIOutperform Votes666.67% Underperform Votes333.33% Trellus HealthN/AN/A Is IQAI or TRLS more profitable? IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat IQ-AI's return on equity.Company Net Margins Return on Equity Return on Assets IQ-AI-77.52% -140.75% -22.03% Trellus Health -12,114.55%-37.95%-22.76% Which has higher earnings & valuation, IQAI or TRLS? IQ-AI has higher revenue and earnings than Trellus Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIQ-AI£538.19K3.71N/AN/AN/ATrellus Health£65.83K53.15-£7.98M-£3.45-0.53 Which has more risk & volatility, IQAI or TRLS? IQ-AI has a beta of 2.25, meaning that its share price is 125% more volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500. Does the media prefer IQAI or TRLS? In the previous week, IQ-AI had 3 more articles in the media than Trellus Health. MarketBeat recorded 3 mentions for IQ-AI and 0 mentions for Trellus Health. Trellus Health's average media sentiment score of 0.00 beat IQ-AI's score of -0.18 indicating that Trellus Health is being referred to more favorably in the news media. Company Overall Sentiment IQ-AI Neutral Trellus Health Neutral SummaryIQ-AI beats Trellus Health on 7 of the 12 factors compared between the two stocks. Get IQ-AI News Delivered to You Automatically Sign up to receive the latest news and ratings for IQAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IQAI vs. The Competition Export to ExcelMetricIQ-AIHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£2.00M£206.30M£5.53B£2.56BDividend Yield17.30%6.68%5.11%4.97%P/E Ratio-13.67219.9622.51132.50Price / Sales3.71437.72397.62227,865.53Price / Cash10.2547.1438.1828.11Price / BookN/A5.236.734.54Net IncomeN/A-£15.55M£3.22B£5.84B7 Day Performance9.49%-0.15%1.38%2.70%1 Month Performance16.13%0.39%2.79%9.91%1 Year Performance-47.06%4.83%15.41%114.85% IQ-AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IQAIIQ-AIN/AGBX 0.81-9.9%N/A-43.8%£1.80M£538,190.00-13.676Earnings ReportGap DownHigh Trading VolumeTRLSTrellus HealthN/AGBX 2+11.1%N/A-7.0%£3.87M£65,831.01-0.5831Gap DownDVRGDeepVergeN/AN/AN/AN/A£1.14M£12.41M-15.0073SENSSensyne HealthN/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware3.1512 of 5 starsGBX 1,585+0.3%GBX 2,800+76.7%-18.8%£681.02M£230.77M58.56734News CoverageINSInstemN/AN/AN/AN/A£199.62M£61.63M5,928.57500Positive NewsKOOKoothN/AGBX 148.88+2.7%GBX 456.67+206.7%-50.2%£54.64M£50.72M13.99478RENXRenalytixN/AGBX 8flatN/A-64.6%£33.16M£9.22M-0.38102Gap UpCOGCambridge CognitionN/AGBX 35.20-0.8%N/A-25.5%£14.74M£15.64M-9.3580Earnings ReportNews CoverageINHCInduction Healthcare GroupN/AGBX 9.26-2.6%N/A-16.0%£8.54M£12.57M-1.6774Gap DownHigh Trading Volume Related Companies and Tools Related Companies Trellus Health Alternatives DeepVerge Alternatives Sensyne Health Alternatives EMIS Group Alternatives Craneware Alternatives Instem Alternatives Kooth Alternatives Renalytix Alternatives Cambridge Cognition Alternatives Induction Healthcare Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IQAI) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQ-AI Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IQ-AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IQAI Stock Free IQAI Stock Alerts